Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study

@inproceedings{Graner2017NeuraminidaseID,
  title={Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study},
  author={Sophie Graner and Tobias Svensson and Anna-Belle Beau and Christine Damase-michel and Anders Engeland and Kari Furu and A Hviid and Siri Eldevik H{\aa}berg and Ditte M\olgaard-Nielsen and Bj{\"o}rn Pasternak and Helle Kieler},
  booktitle={BMJ},
  year={2017}
}
Objective To evaluate the possible effects of exposure to neuraminidase inhibitors during embryo-fetal life with respect to adverse neonatal outcomes and congenital malformations.Design Population based multinational observational cohort study and meta-analysis.Setting National registers covering information on maternal healthcare, births, and prescriptions… CONTINUE READING